Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

31 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

Eligibility Symptomatic Venous Thromboembolism NCT01567917

- 22/01/2019 - 1 Formulaire, 2 Groupes Item, 8 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Incidence of Venous Thromboembolism Following Surgery in Patients With Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01567917

Eligibility Colorectal Cancer NCT00874406

- 02/01/2018 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00874406

Eligibility Colorectal Cancer NCT00059930

- 03/08/2016 - 1 Formulaire, 1 Groupe Item, 16 Eléments de données, 1 Langue
Groupe Item: Criteria
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00059930

Eligibility Colon Cancer NCT00695201

- 10/01/2016 - 1 Formulaire, 2 Groupes Item, 17 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00695201

Eligibility Bloodstream Infection in Cancer Patient DRKS00003368 NCT01544686 DRKS00003368 - Eligibility Bloodstream Infection in Cancer Patient NCT01544686 DRKS00003368

- 04/07/2017 - 1 Formulaire, 2 Groupes Item, 15 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Responsible Party: Maria J.G.T. Vehreschild, Principal Investigator, University of Cologne ClinicalTrials.gov Identifier: NCT01544686 History of Changes Other Study ID Numbers: DRKS00003368 Study First Received: February 22, 2012 Last Updated: December 8, 2015 Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients (COAT) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT01544686

Eligibility Unresectable Liver Metastasis of Colorectal Cancer NCT00869271

- 05/07/2017 - 1 Formulaire, 2 Groupes Item, 11 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Postoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00869271

Eligibility Liver Metastasis NCT00868569

- 24/05/2018 - 1 Formulaire, 2 Groupes Item, 11 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00868569

Eligibility Hepatocellular Carcinoma With Portal Vein Tumor Thrombus NCT01600196

- 17/09/2021 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus; ODM derived from: https://clinicaltrials.gov/show/NCT01600196

Eligibility Hepatocellular Carcinoma NCT01217034

- 27/09/2021 - 1 Formulaire, 2 Groupes Item, 52 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib; ODM derived from: https://clinicaltrials.gov/show/NCT01217034

Eligibility Hepatocellular Carcinoma NCT01833299

- 27/09/2021 - 1 Formulaire, 2 Groupes Item, 32 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01833299

Eligibility Liver Metastasis NCT02316028

- 27/04/2019 - 1 Formulaire, 2 Groupes Item, 12 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC); ODM derived from: https://clinicaltrials.gov/show/NCT02316028

Eligibility Colorectal Neoplasms NCT00643877

- 06/01/2018 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00643877

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial